SG Americas Securities LLC raised its position in shares of LivaNova PLC (NASDAQ:LIVN) by 67.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,939 shares of the company’s stock after buying an additional 7,657 shares during the period. SG Americas Securities LLC’s holdings in LivaNova PLC were worth $1,159,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of LIVN. Ameriprise Financial Inc. increased its stake in LivaNova PLC by 3.6% in the first quarter. Ameriprise Financial Inc. now owns 131,677 shares of the company’s stock worth $6,453,000 after buying an additional 4,545 shares during the period. Meadow Creek Investment Management LLC increased its stake in LivaNova PLC by 11.4% in the first quarter. Meadow Creek Investment Management LLC now owns 2,464 shares of the company’s stock worth $121,000 after buying an additional 252 shares during the period. Icon Advisers Inc. Co. acquired a new stake in LivaNova PLC during the first quarter worth about $333,000. Swiss National Bank increased its stake in LivaNova PLC by 1.8% in the first quarter. Swiss National Bank now owns 72,719 shares of the company’s stock worth $3,564,000 after buying an additional 1,300 shares during the period. Finally, Comerica Bank increased its stake in LivaNova PLC by 3.8% in the first quarter. Comerica Bank now owns 31,907 shares of the company’s stock worth $1,672,000 after buying an additional 1,182 shares during the period. Institutional investors own 82.36% of the company’s stock.

LivaNova PLC (LIVN) opened at 63.66 on Friday. LivaNova PLC has a one year low of $40.83 and a one year high of $64.95. The company’s 50-day moving average is $61.60 and its 200-day moving average is $56.54. The firm has a market capitalization of $3.11 billion, a P/E ratio of 113.68 and a beta of 0.58.

LivaNova PLC (NASDAQ:LIVN) last announced its earnings results on Wednesday, August 9th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.19. LivaNova PLC had a return on equity of 9.08% and a net margin of 2.26%. The firm had revenue of $321.40 million during the quarter, compared to analyst estimates of $315.75 million. The firm’s quarterly revenue was up .1% on a year-over-year basis. Equities analysts forecast that LivaNova PLC will post $3.22 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This story was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this story on another website, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The original version of this story can be read at https://www.watchlistnews.com/sg-americas-securities-llc-acquires-7657-shares-of-livanova-plc-livn/1537378.html.

A number of research firms have recently issued reports on LIVN. WBB Securities downgraded shares of LivaNova PLC from a “hold” rating to a “sell” rating and set a $50.00 price objective on the stock. in a report on Tuesday, August 15th. Needham & Company LLC started coverage on shares of LivaNova PLC in a report on Wednesday, August 23rd. They set a “hold” rating on the stock. Berenberg Bank restated a “buy” rating and set a $70.00 target price on shares of LivaNova PLC in a report on Friday, August 11th. Finally, BidaskClub downgraded shares of LivaNova PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $58.00.

In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $60.76, for a total transaction of $60,760.00. Following the completion of the transaction, the director now owns 58,296 shares in the company, valued at approximately $3,542,064.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have sold a total of 3,000 shares of company stock valued at $183,110 in the last quarter. 0.28% of the stock is owned by corporate insiders.

About LivaNova PLC

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).

Institutional Ownership by Quarter for LivaNova PLC (NASDAQ:LIVN)

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.